These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6018438)

  • 1. B663 in treatment of atypical tuberculous disease.
    Heyworth F
    Med J Aust; 1967 Jan; 1(3):106-7. PubMed ID: 6018438
    [No Abstract]   [Full Text] [Related]  

  • 2. B663 and ethambutol in the treatment of Battey disease.
    Bull PR
    Med J Aust; 1968 Mar; 1(12):511. PubMed ID: 5647373
    [No Abstract]   [Full Text] [Related]  

  • 3. Pellagra-like encephalopathy complicating a multiple drug regimen for the treatment of pulmonary infection due to Mycobacterium avium-intracellulare.
    Brooks-Hill RW; Bishop ME; Vellend H
    Am Rev Respir Dis; 1985 Mar; 131(3):476. PubMed ID: 3156548
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment and long-term follow-up of patients with atypical mycobacterial infections.
    Davidson PT
    Bull Int Union Tuberc; 1976; 51(1):257-61. PubMed ID: 1030293
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterium malmoense--problems with treatment and diagnosis--a case report.
    Banks J; Smith AP; Jenkins PA
    Tubercle; 1983 Sep; 64(3):217-9. PubMed ID: 6636306
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. II. Pathology.
    Angus KW; Gilmour NJ
    J Comp Pathol; 1971 Apr; 81(2):227-34. PubMed ID: 5091663
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria.
    Burjanová B; Urbancik R
    Bibl Tuberc; 1970; 26():154-88. PubMed ID: 4983240
    [No Abstract]   [Full Text] [Related]  

  • 8. The failure of the rimino phenazine B663 (G30320) to reduce the level of experimental Mycobacterium johnei infections in calves.
    Gilmour NJ
    Br Vet J; 1970 Mar; 126(3):v-vi. PubMed ID: 5440612
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium szulgai; a new pathogen causing infection of the lung.
    Davidson PT
    Chest; 1976 Jun; 69(6):799-801. PubMed ID: 1277906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. I. Bacteriology and hypersensitivity.
    Gilmour NJ; Angus KW
    J Comp Pathol; 1971 Apr; 81(2):221-6. PubMed ID: 5091662
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of Mycobacterium fortuitum infections in pulmonary disease.
    Awe RJ; Gangadharam PR; Jenkins DE
    Am Rev Respir Dis; 1973 Nov; 108(5):1230-4. PubMed ID: 4746583
    [No Abstract]   [Full Text] [Related]  

  • 12. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190
    [No Abstract]   [Full Text] [Related]  

  • 14. A ten-year clinical experience with Mycobacterium kansasii.
    Rauscher CR; Kerby G; Ruth WE
    Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
    [No Abstract]   [Full Text] [Related]  

  • 15. Permanently successful chemotherapy in two cases with severe pulmonary mycobacterial disease due to Mycobacterium kansasii and fortuitum, respectively.
    Radenbach KL
    Scand J Respir Dis Suppl; 1972; 80():23-7. PubMed ID: 4510913
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical management of pulmonary tuberculosis due to atypical mycobacteria.
    Hattler BG; Young WG; Sealy WC; Gentry WH; Cox CB
    J Thorac Cardiovasc Surg; 1970 Mar; 59(3):366-71. PubMed ID: 5415082
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of mycobacterial infections of the lungs.
    Savacool JW
    Ann Clin Lab Sci (1971); 1973; 3(2):91-7. PubMed ID: 4575158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lung diseases due to atypical mycobacteria].
    Favez G
    Schweiz Med Wochenschr; 1975 Aug; 105(31):987-91. PubMed ID: 1153999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of disease caused by nontuberculous mycobacteria.
    Bass JB; Hawkins EL
    Arch Intern Med; 1983 Jul; 143(7):1439-41. PubMed ID: 6870414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.